Cargando…

Paracrine factors for neurodegenerative disorders: special emphasis on Parkinson's disease

Detalles Bibliográficos
Autores principales:	Di Santo, Stefano, Widmer, Hans Rudolf
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2016
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4870911/ https://www.ncbi.nlm.nih.gov/pubmed/27212915 http://dx.doi.org/10.4103/1673-5374.180739

Ejemplares similares

Sustained neuronal viability by paracrine factors: new opportunities for endothelial progenitor cell secretome
por: Di Santo, Stefano, et al.
Publicado: (2020)

Nogo-A Neutralization Improves Graft Function in a Rat Model of Parkinson’s Disease
por: Seiler, Stefanie, et al.
Publicado: (2016)

Nogo-A and its functions beyond axonal inhibition: the controversial role of Nogo-A in Parkinson's disease
por: Seiler, Stefanie, et al.
Publicado: (2015)

Therapeutic drug repositioning with special emphasis on neurodegenerative diseases: Threats and issues
por: Kakoti, Bibhuti Bhusan, et al.
Publicado: (2022)

Protecting the infant-parent relationship: special emphasis on perinatal mood and anxiety disorder screening and treatment in neonatal intensive care unit parents
por: Johnson Rolfes, Julie, et al.
Publicado: (2021)

Brain-derived neurotrophic factor in main neurodegenerative diseases
por: Camuso, Serena, et al.
Publicado: (2022)

Propagation of TDP-43 proteinopathy in neurodegenerative disorders
por: Keszycki, Rachel, et al.
Publicado: (2021)

Stress granules: friend or foe in neurodegenerative disorders?
por: Xu, Shanshan, et al.
Publicado: (2023)

Nuclear sphingomyelin in neurodegenerative diseases
por: Albi, Elisabetta, et al.
Publicado: (2021)

Bioelemental patterns in the cerebrospinal fluid as potential biomarkers for neurodegenerative disorders
por: Maass, Fabian, et al.
Publicado: (2018)

Cross-talk between T-cells and gut-microbiota in neurodegenerative disorders
por: Pacheco, Rodrigo
Publicado: (2019)

A perspective on causality assessment in epigenetic research on neurodegenerative disorders
por: Koulousakis, Philippos, et al.
Publicado: (2022)

Olfactory dysfunction as a common biomarker for neurodegenerative and neuropsychiatric disorders
por: Slabik, David, et al.
Publicado: (2022)

hiPSCs for predictive modelling of neurodegenerative diseases: dreaming the possible
por: Rivetti di Val Cervo, Pia, et al.
Publicado: (2021)

Co-Expression of Nogo-A in Dopaminergic Neurons of the Human Substantia Nigra Pars Compacta Is Reduced in Parkinson’s Disease
por: Eyer, Gian-Carlo, et al.
Publicado: (2021)

Hydrogen Ion Dynamics as the Fundamental Link between Neurodegenerative Diseases and Cancer: Its Application to the Therapeutics of Neurodegenerative Diseases with Special Emphasis on Multiple Sclerosis
por: Harguindey, Salvador, et al.
Publicado: (2022)

Tayloring cell populations for neurodegenerative diseases
por: Fortin, Jeff M., et al.
Publicado: (2016)

Microglia-targeting nanotherapeutics for neurodegenerative diseases
por: Zhao, Nanxia, et al.
Publicado: (2020)

Significance of intercellular communication for neurodegenerative diseases
por: Cihankaya, Hilal, et al.
Publicado: (2021)

Overcoming mitochondrial dysfunction in neurodegenerative diseases
por: Pessoa, João, et al.
Publicado: (2022)

Dental pulp stem cells, a paracrine-mediated therapy for the retina
por: Mead, Ben, et al.
Publicado: (2014)

Complement pathway in Alzheimer’s pathology and retinal neurodegenerative disorders – the road ahead
por: Mirzaei, Mehdi, et al.
Publicado: (2019)

The therapeutic potential of nerve growth factor combined with blood-brain barrier modulation by focused ultrasound for neurodegenerative disorders
por: Xhima, Kristiana, et al.
Publicado: (2021)

Protection against neurodegenerative disease on Earth and in space
por: Takamatsu, Yoshiki, et al.
Publicado: (2016)

Insights into the protective role of immunity in neurodegenerative disease
por: Comi, Cristoforo, et al.
Publicado: (2017)

Targeting mechanisms in cognitive training for neurodegenerative diseases
por: Venneri, Annalena, et al.
Publicado: (2020)

Impact of the metabolic syndrome on the evolution of neurodegenerative diseases
por: de A. Boleti, Ana Paula, et al.
Publicado: (2020)

Polyglutamine diseases: looking beyond the neurodegenerative universe
por: Mielcarek, Michal, et al.
Publicado: (2020)

Effects of Ketogenic Diet on Neuroinflammation in Neurodegenerative Diseases
por: Jiang, Ziying, et al.
Publicado: (2022)

Therapeutic potential of lysosomal cathepsins for neurodegenerative diseases
por: Prieto Huarcaya, Susy, et al.
Publicado: (2022)

Enterovirus infection and its relationship with neurodegenerative diseases
por: Sousa, Ivanildo Pedro, et al.
Publicado: (2023)

Antagonization of the Nogo-Receptor 1 Enhances Dopaminergic Fiber Outgrowth of Transplants in a Rat Model of Parkinson’s Disease
por: Seiler, Stefanie, et al.
Publicado: (2017)

Is glial heme oxygenase-1 suppression in neurodegenerative disorders permissive for neural repair?
por: Schipper, Hyman M.
Publicado: (2015)

Disease-associated oligodendrocyte signatures in neurodegenerative disease: the known and unknown
por: Schuster, Kristen H., et al.
Publicado: (2023)

Beneficial effects of date palm fruits on neurodegenerative diseases
por: Essa, Musthafa Mohamed, et al.
Publicado: (2016)

Therapeutic induction of autophagy to modulate neurodegenerative disease progression
por: Hochfeld, Warren E, et al.
Publicado: (2013)

Dysregulation of cholesterol balance in the brain: contribution to neurodegenerative diseases
por: Vance, Jean E.
Publicado: (2012)

Role of myelin sheath energy metabolism in neurodegenerative diseases
por: Ravera, Silvia, et al.
Publicado: (2015)

Tubulin glutamylation: a skeleton key for neurodegenerative diseases
por: van der Laan, Siem, et al.
Publicado: (2019)

Therapeutic potential of trehalose in neurodegenerative diseases: the knowns and unknowns
por: Khalifeh, Masoomeh, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lccpr7bsq4tg0c30p94s84daf8